Cargando…
A randomized, open-label study comparing low-dose clevudine plus adefovir combination therapy with clevudine monotherapy in naïve chronic hepatitis B patients
PURPOSE: Clevudine 30 mg showed potent antiviral activity with a marked post-treatment antiviral effect. However, long-term treatment with clevudine monotherapy induced resistance and myopathy in some cases. The objective of this study is to evaluate the preliminary efficacy and safety of the combin...
Autores principales: | Tak, Won Young, Yang, Jin Mo, Kim, Byung Ik, Baik, Soon Koo, Cheon, Gab Jin, Byun, Kwan Soo, Kim, Do Young, Yoo, Byung Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116600/ https://www.ncbi.nlm.nih.gov/pubmed/25101150 http://dx.doi.org/10.1007/s12072-014-9537-5 |
Ejemplares similares
-
Efficacy of Initial Treatment with Clevudine in Naive Patients with Chronic Hepatitis B
por: Yang, Hyeon Woong, et al.
Publicado: (2010) -
Clevudine Induced Mitochondrial Myopathy
por: Park, Soo-Hyun, et al.
Publicado: (2017) -
Long-Term Treatment Efficacy and Safety of Clevudine Therapy in Naïve Patients with Chronic Hepatitis B
por: Choung, Bum Su, et al.
Publicado: (2012) -
Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study
por: Cho, Eun Young, et al.
Publicado: (2017) -
Virological Response and Muscular Adverse Events during Long-Term Clevudine Therapy in Chronic Hepatitis B Patients
por: Kim, Byung Kook, et al.
Publicado: (2013)